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Background: T1 imaging based on pixel-wise quantification of longitudinal relaxation has the potential to
differentiate between normal and abnormal myocardium. The accuracy of T1 measurement has not been
established nor systematically tested in the presence of health and disease.
Methods: Intra-observer, inter-observer and inter-study reproducibility of T1 imaging was assessed in subjects with
left ventricular hypertrophy (LVH, n = 25) or dilated cardiomyopathy (DCM, n = 43). Thirty-eight subjects with low-
pretest likelihood of cardiomyopathy served as a control group. T1 values were acquired in a single mid-ventricular
short axis slice using modified Look-Locker imaging prior and after the application of gadolinium contrast at 1.5
and 3 T. Analysis was performed with regions of interest (ROI) placed conservatively within the septum or to
include the whole short axis (SAX) myocardium.
Results: Intra-observer, inter-observer and inter-study repeated measurements within the septum showed smaller
mean differences and narrower 95% confidence intervals than repeated short axis ROI measurements. Native T1
values were higher in septal ROIs compared with SAX values at both field strengths (1.5 T: 976 ± 37 vs. 952 ± 41,
p < 0.01; 3 T: 1108 ± 67 vs. 1087 ± 60, p < 0.01). Native T1 values revealed significant mean differences between
controls and patients with LVH for both septal (1.5 T: 26 ± 9, p < 0.01; 3 T: 50 ± 13, p < 0.01) and SAX ROIs (1.5 T:
19 ± 11, p < 0.05; 3 T: 47 ± 19, p < 0.05) with greater differences observed at 3 T versus 1.5 T field strength. Native T1
values revealed significant mean differences between controls and patients with DCM for septal ROI (1.5 T: 29 ± 15,
p < 0.05; 3 T: 55 ± 16, p < 0.01) at both 1.5 T and 3 T, but only for SAX ROIs at 3 T (49 ± 17, p < 0.01). There were no
significant differences in post-contrast T1 values or partition coefficient (λ) between controls and patients.
Conclusion: Conservative septal ROI T1 measurement is a robust technique with excellent intra-observer, inter-
observer and inter-study reproducibility for native and post-contrast T1 value and partition coefficient
measurements. Moreover, native septal T1 values reveal the greatest difference between normal and abnormal
myocardium, which is independent of geometrical alterations of cardiac chamber and wall thickness. We propose
the use of native T1 measurements using conservative septal technique as the standardized approach to
distinguish health from disease assuming diffuse myocardial involvement.
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Quantification of longitudinal relaxation by T1 mapping
provides tissue specific values in line with their compos-
ition and magnetic field strength [1]. Interest in T1
mapping has grown exponentially in recent years, with
promising yield that it can differentiate between normal
and abnormal myocardium in overt cardiac pathologies
[2-6]. However, there are several issues pertaining success-
ful translation of this method into clinical practice.
Current evidence is derived on the basis of single center
studies using a variety of sequences, complex contrast
agent injection schemes, pre and post contrast data acqui-
sition algorithms, different doses and types of contrast
agent, and non-uniform post-processing approaches [2].
Several studies were based on the classical Look-Locker
(or ‘TI scout’) sequence which is widely available due to
its accepted application for determination of the null point
of the myocardium for LGE imaging [7]. The introduction
of modified Look-Locker imaging (MOLLI) offered the
advantage of acquiring data at a standstill diastolic point
of the heart cycle [8]. Despite ongoing development and
novel sequences [9] MOLLI remains the most widely
available T1 mapping technique. Whereas the majority of
published studies relied on the image acquisition in a
single mid-ventricular short axis (mid-SAX) plane, the
differences in approaches to post-processing of myocar-
dial T1 are remarkable ranging from segmental ap-
proaches using the 16–segment model to the inclusion
of the entire myocardium within the mid-SAX plane
[3-6,10]. Segmental approaches uncovered significant
regional variation of the T1 values with extremes be-
tween septal and lateral segments: septal values are
higher and show smaller spread of values than lateral
[9-11]. Furthermore, lateral segments show greater sus-
ceptibility to artifacts. Whether the choice of post-
processing matters in discrimination between health
and disease given the known regional variation of the
T1 values is unknown.
In addition to native and post-contrast myocardial T1
measurements, the calculation of hybrid measures, such
as partition coefficient λ have been reported [12,13].
Furthermore, extracellular volume (ECV) can be calcu-
lated if the hematocrit is known, using the formula (1-
haematocrit)*×λ. Studies varied in their reported T1
values per field strengths, and also in terms of regional
variation of extracellular volume fraction [11-13]. Des-
pite some evidence in healthy volunteers and overt
cardiac pathologies the robustness of the T1 mapping
methodology has not been systematically tested in the
presence of health and disease. In particular, whether al-
tered geometric relations of left ventricular (LV) cardiac
chamber and wall thickness, commonly encountered in
routine clinical patients affects the accuracy and repro-
ducibility of T1 measurements has not been determined.Methods
Consecutive subjects referred for clinical Cardiovascular
Magnetic Resonance (CMR) were invited to participate
in this study. Groups of unrelated subjects were com-
posed to examine the influence of LV chamber size and
wall thickness [14]:
1. LV hypertrophy (LVH; n = 25; IVSd ≥ 12 mm,
LVPWd ≥ 12 mm, increased indexed LV mass but no
increase in LV cavity).
2. Dilated LV cavity (DCM; n = 43; end-diastolic volume
index (EDV index) > 100 ml.m-2, end-systolic volume
index (ESV/index) > 37 ml.m-2, reduction in global
systolic function (ejection fraction (EF) of < 56%), but
no increase in wall thickness).
3. Thirty-eight normotensive subjects with low-pretest
likelihood of cardiomyopathy, normal LV volumes,
mass, and global systolic function, as well as absence
of myocardial Late Gadolinium Enhancement (LGE)
and no regular medication served as a control
group.
Exclusion criteria for all subjects were the generally ac-
cepted contraindications to CMR (implantable devices,
cerebral aneurysm clips, cochlear implants, severe claus-
trophobia) or history of renal disease with a current
eGFR < 30 mL/min/1.73 m2. The study protocol was
reviewed and approved by institutional ethics commit-
tee and written informed consent was obtained from all
participants.
Image acquisition
We integrated native and post-contrast myocardial T1
mapping with MOLLI into our routine imaging protocol
for the determination of the underlying etiology of car-
diomyopathy as previously described [3]. Studies were
performed at either 1.5 or 3 T field strength (Philips
Healthcare, Best, The Netherlands) on clinical scanners
equipped with advanced cardiac packages and 32-channel
coils. After standardized patient specific planning [15],
volumetric cavity assessment was obtained by whole-heart
coverage of gapless short-axis slices. Thereafter, cine-
images of 3 long-axis views (4-chamber, 2-chamber and 3-
chamber view) and transverse axial views were acquired.
All cine-images were acquired using a balanced steady-
state free precession sequence in combination with
parallel imaging (SENSitivity Encoding, factor 2) and
retrospective gating during a gentle expiratory breath-
hold ((TE/TR/flip-angle: 1.7 ms/3.4 ms/60°, spatial reso-
lution 1.8 × 1.8 × 8 mm). LGE imaging was performed in
corresponding views in all subjects using a mid-diastolic
inversion prepared 2-dimensional gradient echo sequence
(TE/TR/flip-angle 2.0 ms/3.4 ms/25°, spatial resolution
1.8 × 2 × 8 mm, with a patient-adapted prepulse delay)
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kg body weight). T1 mapping was performed in a single
mid-ventricular short-axis slice prior to administration
of 0.2 mmol/kg of gadobutrol and prior to the LGE im-
aging. Parameters for native and post-contrast MOLLI
imaging were identical (FOV 320 × 320; TE/TR/flip-
angle: 1.57 ms/3.3 ms/50°, interpolated voxel size 0.9 ×
0.9 × 8 mm, phase encoding steps n = 166, HR adapted
trigger delay, with 11 (3-3-5) phase sampling arrange-
ments. An adiabatic pre-pulse was used to achieve a
complete inversion.Image analysis
All routine CMR analysis was performed using commer-
cially available software (ViewForum, Extended Work-
space, Philips Healthcare, The Netherlands). Endocardial
LV borders were manually traced at end-diastole and
end-systole. The papillary muscles were included as part
of the LV cavity volume. LV end-diastolic (EDV) and
end-systolic (ESV) volumes were determined using
Simpson’s rule. Ejection fraction (EF) was computed as
EDV-ESV/EDV. All volumetric indices were normalized
to body surface area (BSA).
For each subject T1, relaxation values were measured
separately by two independent observers. Chosen re-
gions of interest (ROIs) were automatically propagated
across all eleven images in the MOLLI sequence with a
prior image- co-registration step for motion-correction
[3]. Care was particularly taken to avoid ‘contamination’
with signal from the blood pool.
Two main approaches to place myocardial ROIs within
the mid-SAX slice were examined: Septal and SAX myo-
cardial ROI (Figure 1). An additional lateral myocardial
ROI was also examined for regional differences in T1
values. In addition to the T1 values of native myocardium
and blood pool, we calculated lambda (λ), a marker of
interstitial contrast agent accumulation according to the
formula λ = [Δ R1myocardium]/[Δ R1bloodpool] pre and
post gadolinium contrast where R1 = 1/T1 [11,12].Figure 1 Sample short axis images depicting ROIs places conservative
myocardium.Statistical analysis
Statistical analysis was performed using SPSS software
(SPSS Inc., Chicago, IL, USA, version 20.0). Departures
from normality were detected using Kolmogorov-Smirnov
test. Mean differences were examined by one-way and re-
peated measures ANOVA with Bonferroni post-hoc tests,
as appropriate. Comparisons of values between two field
strengths, and post-processing approaches were per-
formed using paired and unpaired t-tests and one-way
analysis of variance, as appropriate. Agreements between
two methods, different observers, and repeated measure-
ments of a single observer were determined by linear
regressions, mean differences (bias), 95% confidence inter-
val, and relative differences (mean difference of two tech-
niques/measurements as percentage of their mean value)
according to the methods of Bland and Altman. Values are
reported as mean±SD and a p-value of less than 0.05 was
considered statistically significant.Results
Subject characteristics are presented in Table 1. There
was a predominance of male subjects in all groups. Pa-
tients with DCM were older than normal subjects and
patients with LVH. In comparison to controls, patients
with LVH had increased LV mass but similar LV vol-
umes and function. Patients with DCM had increased
LV volumes with reduced global systolic function.
There were significant regional differences between the
septal and lateral ROIs for nativeT1, but not for post-
contrast values. At both 1.5 T and 3 T field strengths, na-
tive septal T1 values were higher than SAX or lateral T1
values (mean of all subjects: T1 values, septal vs. SAX vs.
lateral (ms): 1.5 T: 976 ± 37 vs. 952 ± 41 vs. 943 ± 45, p <
0.01; 3 T: 1108 ± 67 vs. 1087 ± 60 vs. 1052 ± 72, p < 0.01).
The partition coefficient λ was lower at 1.5 T than 3 T and
showed no regional variation at either field strength (mean
of all subjects, 1.5 T: septal vs. lateral vs. SAX: 0.42 ± 0.09
vs. 0.43 ± 0.10 and 0.42 ± 0.08; 3 T: 0.47 ± 0.11 vs. 0.46 ±
0.11 and 0.46 ± 0.09). We observed a wide variability ofly within the septum, lateral wall or around the whole
Table 1 Subject characteristics
Variables Normal LVH DCM
(n = 38) (n = 25) (n = 43)
Gender (n, % male) 25 (65) 16(67) 29 (67)
Age (years) 49 ± 13 50 ± 13 57 ± 15
Heart rate (bpm) 66 ± 10 65 ± 10 63 ± 9
Body surface area (m2) 1.9 ± 0.1 1.9 ± 0.2 1.9 ± 0.2
EDV index (ml.m-2) 80 ± 15 72 ± 21 133 ± 37*
ESV index (ml.m-2) 32 ± 9 29 ± 12 87 ± 37*
Ejection fraction (%) 61 ± 6 61 ± 12 36 ± 1*3
Mass index (g.m-2) 52 ± 15 90 ± 31* 89 ± 29*
LVH left ventricular hypertrophy, DCM dilated cardiomyopathy, BSA body
surface area, EDV end-diastolic volume, ESV end-systolic volume, one way
ANOVA, Bonferroni post-hoc tests for the differences from control group, *p <
0.05 is considered significant.
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of variability (CoV) of 21-28%.
Table 2 lists mean differences (MDs) between septal
T1 values and those derived using SAX ROIs or lateral
measurements. For both field strengths and all groups,
the MDs were greater for lateral measurements than
SAX ROIs (p < 0.05 for all). Also, MDs and SDs were
greater in both groups of patients than healthy subjects
for all measures, and the spread of differences was con-
siderably greater for the DCM group than the LVH
group (p < 0.05 for all).
Table 3 lists the effective differences between controls
and patient groups. Native T1 myocardium revealed sig-
nificant difference between controls and patients (p < 0.05)
for septal and SAX approach, with greater differences ob-
served at 3 T compared with 1.5 T field strength. Post-
contrast measurements at either field strength showed no
significant difference between controls and patient groups
within the current cohort size. The partition coefficient λ
showed no significant difference between the groups for
either field strength. Figure 2 summarizes the mean differ-
ences for both 1.5 T and 3 T field strength.Table 2 Mean differences (MD) in T1values between septal an
ventricular hypertrophy, DCM – dilated cardiomyopathy)
MOLLI Native T1 values (MD ± SD) Post-contra
1.5 T Septal vs. SAX Septal vs. Lateral Septal vs. SAX
Normal 16 ± 11 21 ± 43 6 ± 14
LVH 20 ± 21 29 ± 49 11 ± 19
DCM 28 ± 31 50 ± 64 19 ± 22
3 T
Normal 21 ± 22 46 ± 46 10 ± 18
LVH 16 ± 41 40 ± 37 17 ± 26
DCM 26 ± 49 55 ± 92 24 ± 38
For both field strengths and all groups, the MDs were greater for lateral measuremTable 4 lists results of intra- and inter-observer reprodu-
cibility and inter-study reproducibility of measurements.
Intra-observer reproducibility for both field strengths sep-
tal measurements showed smaller MDs and narrower 95%
confidence intervals. Compared to post-contrast values
and partition coefficient, native T1 values measured in the
septum showed superior intra-observer reproducibility at
both field strengths. Figure 3 summarizes mean differ-
ences and 95% confidence intervals for all three reprodu-
cibility tests for septal vs. SAX native and post-contrast
T1. For both field strengths septal measurements show
smaller MDs and narrower 95% confidence intervals and
higher reproducibility compared with the SAX approach.
Inter-study reproducibility was performed in subgroups
of normal subjects (n = 12), patients with dilated cavity
(n = 6) and subjects with increased LV wall thickness
(n = 5) who underwent a second CMR study within up to
1-month interval with no interim change in clinical status
or medication. Septal and SAX approaches showed excel-
lent reproducibility and agreements in both field strengths
whereas post-contrast T1 measurements showed high
variability irrespective of sequence or field strength. Re-
producibility of partition coefficient λ was inferior to that
observed with native T1 measurements.
Discussion
Results of our study reveal that the choice of septal vs.
SAX approach matters with respect to reproducibility of
measurements and detection of effective difference be-
tween health and disease assuming diffuse myocardial
involvement. We demonstrate that using a conservative
septal approach is the more reproducible within and
between observers compared with evaluation of the
complete SAX slice. Our results also reveal that using
septal approach is also most robust for measurements in
repeated studies within the same subject. We further
show that septal T1 measurements in native myocar-
dium reveal the greatest difference between health and
disease, irrespective of the field strength or geometricald SAX ROIs or lateral measurements (LVH – left
st T1 values (MD ± SD) Lambda (MD ± SD)
Septal vs. Lateral Septal vs. SAX Septal vs. Lateral
11 ± 28 0.002 ± 0.03 0.003 ± 0.06
13 ± 39 0.01 ± 0.04 0.02 ± 0.09
25 ± 55 0.02 ± 0.04 0.02 ± 0.11
13 ± 20 0.002 ± 0.08 0.02 ± 0.09
16 ± 37 0.01 ± 0.06 0.01 ± 0.10
27 ± 43 0.02 ± 0.10 0.02 ± 0.12
ents than SAX ROIs (p < 0.05 for all).
Table 3 Detecting the difference between controls and patients using septal and SAX myocardial ROI, sequence, and
field strengths
Native T1 values Post-contrast T1 values Lambda
(MD ± SD) (MD ± SD) (MD ± SD)
LVH
Septal SAX Septal SAX Septal SAX
1.5 T 26 ± 9** 19 ± 11* 24 ± 26 27 ± 28 0.02 ± 0.04 0.03 ± 0.03
3 T 50 ± 13** 47 ± 19* 9 ± 16 7 ± 17 0.07 ± 05 0.04 ± 0.04
DCM
Septal SAX Septal SAX Septal SAX
1.5 T 29 ± 15* 12 ± 17 11 ± 16 12 ± 20 0.01 ± 0.03 0.01 ± 0.03
3 T 55 ± 16** 49 ± 17** 24 ± 22 29 ± 19 0.02 ± 0.03 0.01 ± 0.04
Absolute mean difference (MD) and standard errors (SE) between controls and separate patient groups are derived with Student t-test, p-value < 0.05*, < 0.01**.
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provide a proof of concept that T1 measurement derived
conservatively within the septal myocardium should be
adopted as the standardized approach in measurement
of T1 values when assuming diffuse involvement. Using
this approach, we further propose the native T1 as the
best discriminatory measure between health and disease.
Several studies report on excellent reproducibility of T1
measurements prior to or after administration of the con-
trast agent [8,9,12,13]. These studies however employed a
variety of sequences and sampling approaches and pre-
dominantly focused on a healthy population. A single pre-
vious study examined the reproducibility in health and
disease [16], based on calculation of lambda and ECV.Figure 2 Comparison of T1 values between controls and subjects wit
expressed as absolute mean difference (MD) ± SD (ms). Differences with stOur study concords with many of the reported findings
including higher values found in patients and in terms of
variability of measures. Our study expands on these previ-
ous findings, by including the native T1 values, and a
head-to head comparison with the postcontrast T1 and
lambda values, performed at both field strengths. Further-
more, we specifically placed our focus on the accuracy of
post-processing in relation to altered chamber dimensions
and wall thickness [14], as well as in light of known re-
gional variations of T1 values [8,9]. We show that native
T1 measurements using septal or SAX approach are
robust with an overall good intra-observer and inter-
observer reproducibility and irrespective of the field
strength. We further report that using conservative septalh LVH or DCM at 1.5 T and 3 T field strengths. Results are
atistical significance are identified by * p < 0.05 and ** p < 0.01.
Table 4 Intra-observer, inter-observer and inter-study reproducibility of measurements for all subjects
Intraobserver 1.5 T 3 T
Septal SAX Septal SAX
Native T1
MD ± SD (ms) 3 ± 11 −16 ± 23 3 ± 13 −6 ± 16
CoV (%) 1.1 2.3 1.2 1.5
Agreement (r) 0.84** 0.72** 0.87** 0.74**
Post-contrast T1
MD ± SD (ms) 5 ± 12 3 ± 24 −6 ± 15 −3 ± 13
CoV (%) 3.1 6.6 3.2 3.2
Agreement (r) 0.78** 0.53* 0.79** 0.62**
Lambda
MD ± SD 0.014 ± 0.009 −0.017 ± 0.013 0.017 ± 0.002 0.019 ± 0.019
CoV (%) 4.1 5.2 5.1 5.9
Agreement (r) 0.81** 0.69** 0.78** 0.61**
Interobserver 1.5 T 3 T
Septal SAX Septal SAX
Native T1
MD ± SD (ms) −1.5 ± 19 2.3 ± 24 0.3 ± 15 −2.9 ± 49
CoV (%) 4.3 6.9 1.4 2.7
Agreement (r) 0.89** 0.73** 0.93** 0.75**
Post-contrast T1
MD ± SD (ms) −6.3 ± 52 −6.9 ± 53 6.2 ± 71 −8.4 ± 79
CoV (%) 4.3 7.1 2.8 3.3
Agreement (r) 0.79** 0.69** 0.81** 0.54**
Lambda
MD ± SD 0.013 ± 0.019 −0.017 ± 0.002 0.019 ± 0.008 0.011 ± 0.003
CoV (%) 7.2 7.9 9.1 11.7
Agreement (r) 0.71** 0.59** 0.68** 0.53**
Interstudy 1.5 T 3 T
Septal SAX Septal SAX
Native T1
MD ± SD (msec) 2.4 ± 9.2 6.1 ± 21 −1.5 ± 12 4.9 ± 18
CoV (%) 1.2 4.5 3.6 8.4
Agreement (r) 0.92** 0.78** 0.95** 0.86**
Post-contrast T1
MD ± SD (ms) −8 ± 54 35 ± 72 19 ± 65 31 ± 62
CoV (%) 9.0 12 12 15
Agreement (r) 0.62** 0.45* 0.55** 0.41**
Lambda
MD ± SD 0.017 ± 0.021 0.021 ± 0.029 0.016 ± 0.018 0.019 ± 0.035
CoV (%) 4.2 6.1 3.5 7.8
Agreement (r) 0.79** 0.69** 0.82** 0.73**
Data is expressed as mean ± SD, CoV coefficient of variability, r = Pearson correlation coefficient for agreement between two measurements, p-value < 0.05*,
< 0.01** for significant association.
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Figure 3 Intra-observer, inter-observer and inter-study variability at 1.5 T and 3 T field strength. Results are expressed as mean difference
(MD) between repeated measurements ± SD (ms).
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and hybrid measures in reproducibility and effect size. A
few considerations may explain this observation. First, we
reproduce previously reported regional variations with a
signal gradient in T1 values between the septal and the
lateral wall, irrespective of the field strength [9,13]. The
SAX approach is a combination of all T1 values observed
within the whole SAX slice and as such also includes the
lateral T1 values, which show a significantly higher vari-
ability than the septum. The observed regional differences
unlikely represent a true difference in tissue composition(i.e. a true tissue dependent difference in longitudinal re-
laxation), in accord with several previous studies demon-
strating homogeneity of diffuse myocardial fibrosis in
subjects with DCM [17,18]. Instead, the observed differ-
ences are likely related to a number of confounding
factors, including magnetic susceptibility artifacts, mea-
surement errors and issues pertaining receiver coil sen-
sitivity in SENSE imaging [13,19]. The sampling within
the lateral wall suffers with high likelihood from inclu-
sion of voxels outside of the true myocardium or at the
very least, the partial volumes of straddling voxels on
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resulting in a mixture of T1 values. Additionally, the sig-
nal gradient between septal and lateral myocardium due
to greater distance from the receiver coil elements for
the latter has been long recognized. The difficulty in
drawing ROIs within the lateral wall renders the SAX
approach less robust and the benefit of its inclusion into
the T1 sampling questionable.
We also show that whereas post-contrast measurements
are relatively observer-independent, these measurements
are less reliable when cross-correlated between different
studies within the same subject. These findings concord
with the previous postulations indicating the relatively dy-
namic post-contrast evolution of T1 myocardial values
and an ~150-200 ms change within the usual time-frame
between 10–25 minutes when most of contrast-enhanced
studies are performed [20]. Typical timing of our post-
contrast T1 acquisition coincided with the LGE studies,
therefore, we observed that the discrepancy in the post-
contrast T1 values is inherently more common in those
cases where a shorter second study was focused on the ac-
quisition of T1 mapping dataset. The partition coefficient
λ, which also accounts for the differences between native
and post-contrast acquisitions, is comparably more robust
than simple post-contrast T1 measurements for the inter-
study comparisons. Our study showed no significant re-
gional differences in λ, however it revealed a considerable
difference in values between 1.5 T and 3 T, as previously
also shown by Sharma et al. [21]. A more heterogeneous
representation of subjects in the current study and inclu-
sion of more pathological cases in the 3 T cohort may also
account for this observation.
The ultimate goal of T1 imaging is a robust clinical
application for differentiation between normal and ab-
normal myocardium [3-5,22-25]. Contrasting the previ-
ous studies, we examined the value of T1 measures with
respect to commonly occurring patterns of cardiac path-
ology presenting in a real clinical practice [26]. Within
subject comparison of sampling approaches and the use
of post-contrast and hybrid measures reveals that con-
servative septal T1 measurements provide the greatest
measurable difference between health and disease when
assuming diffuse involvement. Detection of tissue differ-
ences is most effective using a native T1 measurement
with a standardized approach of a septal approach, which
is independent of changes of left ventricular thickness due
to myocardial disease process, such as hypertrophy or cav-
ity dilatation. In the current study particular attention was
placed on the motion correction as well as the placement
of the ROIs conservatively within the myocardium to
avoid contamination with the blood pool. Whereas in-
creased wall thickness clearly simplifies ROI placement
within the myocardium, the likelihood of measurement of
error in the thinned dilated myocardium is considerablyhigher and further compromised by difficulty in breath-
holding resulting in respiratory motion. We also show
that T1 mapping using MOLLI sequence is realistic and
easily incorporated into routine clinical CMR examin-
ation protocols.Limitations
Several limitations pertain this study. The small sample
size may limit the generalization of present findings as
well as assessment of multifactorial influences on T1
measurements. For routine clinical application of T1
mapping, studies with larger subject samples are re-
quired to determine normal standard ranges for T1
values. Clinical outcome data must then be assembled
to confirm clinical relevance of these measurements. T1
sampling in the septum of a single short axis slice is
based on assumption that it is representative of a diffuse
myocardial process. Future studies using whole-heart
acquisitions with lower susceptibility to regional variations
in T1 values are needed to determine and understand the
relevant regional variation. Inferior inter-study reproduci-
bility of the partition coefficient λ may be explained by
changes in hematocrit between scans. We did not collect
blood samples for determination of hematocrit from these
healthy volunteers. As this study was based on sampling
from clinical environment, individuals have not undergone
parallel assessments on both field strengths, thus, our
study lacks the comparative data between the two field
strengths. Finally, T1 values obtained by our group in con-
trol and patient subgroups are relatively lower than those
reported by other groups [6,13], indicating the need for
cross-center and cross-vendor comparison of sequences.Conclusions
Conservative septal ROI T1 measurement is a robust tech-
nique with excellent intra-observer, inter-observer and
inter-study reproducibility for native and post-contrast T1
value and partition coefficient measurements. Moreover,
native septal T1 values reveal the greatest difference be-
tween normal and abnormal myocardium, which is in-
dependent of geometrical alterations of cardiac chamber
and wall thickness. We propose the use of native T1
measurements using conservative septal technique as
the standardized approach to distinguish health from
disease assuming diffuse myocardial involvement. The
superior performance is afforded by the ability to elim-
inate measurement errors, sampling of voxels straddling
the myocardial-blood pool interface, and reduced signal
in the lateral wall.Competing interests
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